°­ÀǽÅûRegistration

ÀÓ»ó¾àÇÐ

Ȩhome > °­ÀǽÅû > °ú¸ñº°°­ÀÇ > ÀÓ»ó¾àÇÐ

°­Á¼Ұ³ ¹× ¸ñÂ÷
  • ÆÐÅ°ÁöÀ̹ÌÁö

    °­Á¸í
    ½ÇÀüÀÓ»ó¾àÇÐ 4 [¼ÒÈ­±â Áúȯ/½ÅÀå Áúȯ]
    °­Á¼Ұ³
    º» °­ÀǸ¦ ¼ö°­ÇÏ´Â Àϼ± ¾à»ç´ÔµéÀº ¼±ÁøÀÓ»ó¾àÇп¡ ´ëÇÑ °³³ä°ú Áö½ÄÀ» ȹµæÇÏ¿© ¾à¹« ÇöÀå¿¡¼­ ȯÀÚ¿¡ ´ëÇÑ Ä¡·á¸¦ °­È­ÇÏ°í À̸¦ ½ÇÁ¦ÀûÀ¸·Î Àû¿ëÇÔÀ¸·Î½á ¾à±¹ °æ¿µ°ú Á÷´ÉÀÇ Àü¹®¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

    °¢ °úÁ¤Àº Áúȯº° º´Å»ý¸®, ÀÓ»óÁõ»ó, ¾à¹°Ä¡·á¸¦ Áß½ÉÀ¸·Î °­ÀÇ°¡ ÁøÇàµÇ¸ç,
    º» °­ÀÇ [ÀÓ»ó¾àÇÐ Session 4 ¼ÒÈ­±â Áúȯ/½ÅÀå Áúȯ]Àº Áúȯº° º» °­Á·Π±Ë¾ç Áúȯ, Àå Áúȯ, ¾ËÄݼº °£Áúȯ, ¹ÙÀÌ·¯½º¼º °£¿°, À§¾Ï, ±Þ¼º½ÅºÎÀü, ½ÅÀå ÀÌ½Ä µîÀÇ ¼¼ºÎÀûÀÎ Áö½ÄÀ» ½ÀµæÇÒ ¼ö ÀÖ´Â °­ÁÂÀÔ´Ï´Ù.

    º» °­ÀÇ Session 4 [¼ÒÈ­±â/½ÅÀå Áúȯ]Àº Áúȯº° º» °­Á·Π±Ë¾ç Áúȯ, Àå Áúȯ, ¾ËÄݼº °£Áúȯ, ¹ÙÀÌ·¯½º¼º °£¿°, À§¾Ï, ±Þ¼º½ÅºÎÀü, ½ÅÀå ÀÌ½Ä µîÀÇ ¼¼ºÎÀûÀÎ Áö½ÄÀ» ½ÀµæÇÒ ¼ö ÀÖ´Â °­ÁÂÀÔ´Ï´Ù.

    [°­»ç¼Ò°³]

    ¼­Èñ³² Pharm.D.

    - °æÈñ´ëÇб³ ¾àÇаú Á¹¾÷
    - University of Florida, Pharm.D.
    - Çö) ¾àÇÐ ´ëÇÐ Ãâ°­
    - Çö) °­ºÏ»ï¼ºº´¿ø ¾àÁ¦°ú

    À¯Èñ¿ø Pharm.D.

    - µ¿´ö¿©ÀÚ´ëÇб³ ¾àÇаú Á¹¾÷
    - Medical Terminology °úÁ¤ ¼ö·á, Beth Israel Deaconess Medical Center, Brookline, MA, USA
    - University of Florida, Pharm.D.
    - ¹Ì±¹ ¾à»ç
    - Àü) 15³â°£ ¹Ì±¹ º´¿ø, ¾à±¹ ±Ù¹«
    - Àü) Á¦ÁÖ¾à»çȸ ¿¬¼ö±³À° °­ÀÇ
    - Çö) ¼­¿ï´ëÇб³ ¾àÇдëÇÐ ¾àÇבּ¸¼Ò ¾à·áÀü¹®ÁöµµÀÚ ±³À°°úÁ¤ °­ÀÇ
    - Çö) ¶óÀÌÇÁ ¾à±¹ °æ¿µ

    ±èÁ¾À± Pharm.D.

    - °æÈñ´ëÇб³ ¾àÇаú
    - °æÈñ´ëÇб³ ´ëÇпø ¼®»ç
    - University of Florida, Pharm.D.
    - Àü) ³ì½ÊÀÚ °³¹ßÆÀ
    - Àü) ¼­¿ï¾Æ»êº´¿ø ¾àÁ¦ÆÀ
    - Çö) »ç°ú³ª¹« Àӻ󿬱¸¼Ò ¿¬±¸¿ø

    ¾ç¼ºÈñ Pharm.D.

    - ¼­¿ï´ëÇб³ ¾àÇаú Á¹¾÷
    - University of Florida, Pharm.D.
    - Àü) °¡Å縯´ëÇб³ °­³²¼º¸ðº´¿ø ¾àÁ¦°ú
    - Àü) Çѱ¹º´¿ø ¾àÁ¦°ú
    - Àü) Á¦ÁÖ ÇѶó´ëÇÐ ÀÓ»ó¾à¸®ÇÐ °­»ç
    - Çö) Medstat(ÀÇÇÐÅë°è ÄÁ¼³ÆÃ) ´ëÇ¥

    ÀÓÇöÁ¤ Pharm.D., BCOP

    - ¼÷¸í¿©´ë ¾àÇаú
    - University of Florida, Pharm.D.
    - Board of Pharmaceutical Specialties, Oncology Pharmacy
    Àü) ¼÷¸í¿©´ë ÀÓ»ó¾àÇдëÇпø, ´ö¼º¿©´ë ¾àÇдëÇÐ Ãâ°­
    Çö) »ï¼º¼­¿ïº´¿ø ¾àÁ¦ºÎ
    °­Á ±â°£/°¡°Ý
    50 / 250,000¿ø
    ±³Àçºñ
    10,000¿ø
    °­Á¸ñÂ÷
    1) Peptic Ulcer (1)
    2) Peptic Ulcer (2) & Irritable bowel syndrome
    3) ¿°Áõ¼º ÀåÁúȯ
    4) ½ÅÀå ÇغÎÇаú »ý¸®ÇÐ
    5) ü¾× ¹× ÀüÇØÁú Àå¾Ö
    6) Cancers in GI
    7) Viral Hepatitis
    8) ±Þ¼º ½ÅºÎÀü
    9) ¸¸¼º½ÅÀåÁúȯ
    10) »ê¿°±âÀå¾Ö
    11) ¾à¹°À¯¹ß½ÅÀåÁúȯ
    12) Drug Dosing in Renal Insufficiency
    13) Transplantation in the Treatment of Renal Failure
    14) Treatment of URINARY TRACT INFECTIONS
    15) Erectile Dysfunction (ED)
    16) ¿À½É & ±¸Åä / GI & Enterotoxigenic poisonings
    17) º¯ºñ & ¼³»ç
    18) Intra Abdominal Infection/Acute VaricealHemorrhage
    19) ¾ËÄÚ¿Ã °£Áúȯ
No °­ÁÂ¸í ´ã´ç±³¼ö ¼ö°­±â°£ ¼ö°­·á ±³Àçºñ °­ÀÇ»ùÇÄ ¼ö°­½Åû
1 ½ÇÀüÀÓ»ó¾àÇÐ 1 [ÀÓ»ó¾àÇÐ ±âÃÊ] ¹Ì±¹ Pharm.D. 16°­
(30ÀÏ)
200,000¿ø15,000¿ø  ¼ö°­
2 ½ÇÀüÀÓ»ó¾àÇÐ 2 [È£Èí±â/ÇǺÎ/¾È°ú Áúȯ] ¹Ì±¹ Pharm.D. 15°­
(30ÀÏ)
200,000¿ø15,000¿ø  ¼ö°­
3 ½ÇÀüÀÓ»ó¾àÇÐ 3 [³»ºÐºñ Áúȯ/½ÉÇ÷°ü Áúȯ] ¹Ì±¹ Pharm.D. 18°­
(50ÀÏ)
250,000¿ø15,000¿ø  ¼ö°­
4 ½ÇÀüÀÓ»ó¾àÇÐ 4 [¼ÒÈ­±â Áúȯ/½ÅÀå Áúȯ] ¹Ì±¹ Pharm.D. 19°­
(50ÀÏ)
250,000¿ø10,000¿ø  ¼ö°­
5 ½ÇÀüÀÓ»ó¾àÇÐ 5 [½Å°æÁúȯ/Á¤½Å Áúȯ/¸é¿ª Áúȯ] ¹Ì±¹ Pharm.D. 15°­
(30ÀÏ)
200,000¿ø10,000¿ø  ¼ö°­

¸ð¹ÙÀϹöÀü